NeuroQ

GUDID B133NEUROQ382104290

NeuroQ™ has been developed to aid in the assessment of human brain scans through quantification of mean pixel values lying within standardized regions of interest, and to provide quantified comparisons with brain scans derived from FDG-PET studies of defined groups having no identified neuropsychiatric disease or symptoms, i.e., asymptomatic controls (AC). The Program provides automated analysis of brain PET scans, with output that includes quantification of relative activity in 240 different brain regions, as well as measures of the magnitude and statistical significance with which activity in each region differs from mean activity values of brain regions in the AC database. The program can be used to compare activity in brain regions of individual scans between two studies from the same patient, between symmetric regions of interest within the brain PET study, and to perform an image fusion of the patients PET and CT data. The program can also be used to for assisting in the assessment of prognosis in patients undergoing dementia evaluation with respect to the likelihood of progression of symptomatic disease, to provide analysis of amyloid uptake levels in the brain, and to evaluate and to provide a quantitative analysis of uptake levels in basal ganglia structures of the brain. The program processes the studies automatically, however, user verification of output is required and manual processing capability is provided.

SYNTERMED INCORPORATED

Multidisciplinary medical image management software
Primary Device IDB133NEUROQ382104290
NIH Device Record Keybad294d6-6cbd-4924-b630-67f69e67bf91
Commercial Distribution StatusIn Commercial Distribution
Brand NameNeuroQ
Version Model Number3.80.20210429.143255
Company DUNS113727205
Company NameSYNTERMED INCORPORATED
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kitfalse
Device Combination Productfalse
Single Usetrue
Lot Batchfalse
Serial Numberfalse
Manufacturing Datefalse
Expiration Datefalse
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptionfalse
OTC Over-The-Counterfalse

Device Identifiers

Device Issuing AgencyDevice ID
HIBCCB133NEUROQ382104290 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

FDA Product Code

KPSSystem, Tomography, Computed, Emission

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2021-06-04
Device Publish Date2021-05-27

On-Brand Devices [NeuroQ]

B133NEUROQ1NeuroQ™ has been developed to aid in the assessment of human brain scans through quantificatio
B133NEUROQ0NeuroQ™ has been developed to aid in the assessment of human brain scans through quantificatio
B133NEUROQ382104290NeuroQ™ has been developed to aid in the assessment of human brain scans through quantificatio
B133NEUROQ382112070NeuroQ™ has been developed to aid in the assessment of human brain scans through quantificatio

Trademark Results [NeuroQ]

Mark Image

Registration | Serial
Company
Trademark
Application Date
NEUROQ
NEUROQ
88650282 not registered Live/Pending
LifeSeasons, Inc.
2019-10-10
NEUROQ
NEUROQ
88650272 not registered Live/Pending
LifeSeasons, Inc.
2019-10-10
NEUROQ
NEUROQ
76007003 not registered Dead/Abandoned
Deltex (Guernsey) Limited
2000-03-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.